Skip to main content
. Author manuscript; available in PMC: 2016 Feb 16.
Published in final edited form as: J Med Chem. 2011 Jun 7;54(13):4678–4693. doi: 10.1021/jm2003427

Scheme 2a.

Scheme 2a

a (a) EDCI, HOBt, NMM, CH3OCH3NH·HCl, CH2Cl2, 51–95%; (b) 3,4,5-trimethoxyphenyl-magnesium bromide, THF, 48–78%; (c) LAH, −78 °C, THF, 85%; (d) Dess–Martin reagent, CH2Cl2, 81%; (e) EDCI, HOBt, NMM, 3,4,5-trimethoxybenzoic acid, CH2Cl2, 58%.

HHS Vulnerability Disclosure